SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-521592"
 

Search: onr:"swepub:oai:DiVA.org:uu-521592" > White matter volume...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

White matter volume and treatment with selective progesterone receptor modulator in patients with premenstrual dysphoric disorder

Kaltsouni, Elisavet (author)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Institutionen för kvinnors och barns hälsa
Wikström, Johan, Professor, 1964- (author)
Uppsala universitet,Institutionen för kirurgiska vetenskaper
Lanzenberger, Rupert (author)
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria;Comprehensive Center for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, Vienna, Austria
show more...
Sundström Poromaa, Inger, 1964- (author)
Uppsala universitet,Reproduktiv hälsa
Comasco, Erika, 1982- (author)
Uppsala universitet,Neuropsykofarmakologi,Science for Life Laboratory, SciLifeLab
show less...
 (creator_code:org_t)
Elsevier, 2024
2024
English.
In: Psychoneuroendocrinology. - : Elsevier. - 0306-4530 .- 1873-3360. ; 163
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Premenstrual dysphoric disorder (PMDD) is a mood disorder for which selective progesterone receptor modulator (SPRM) treatment has been demonstrated to be beneficial. The neural signatures of this treatment have been so far identified as greater fronto-cingulate reactivity during aggressive response to provocation, but no changes in terms of gray matter structure. White matter has recently been found to differ between patients with PMDD and healthy controls. The present study thus sought to investigate the relationship between white matter volume and SPRM treatment in patients with PMDD. A pharmaco-neuroimaging study was conducted on patients with PMDD participating in a randomized controlled trial. Participants underwent magnetic resonance imaging before and after treatment randomization to ulipristal acetate (an SPRM), or placebo, for three months. The interaction effect of treatment by time on white matter volume (WMV) was assessed. Voxel based morphometry analyses were performed on both a whole brain exploratory level and on regions of interest. No treatment effect was observed on WMV in any region, including the anterior thalamic radiations, cingulum, forceps minor, fornix, inferior fronto-occipital fasciculus, superior cerebellar peduncle, superior longitudinal fasciculus, and uncinate fasciculus. This is the first finding to indicate that no white matter volume alterations follow three-month progesterone antagonism, suggesting that white matter volume does not participate in symptom relief upon SPRM treatment for PMDD.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)

Keyword

PMDD
White matter volume
Progesterone antagonism
Ovarian hormones
VBM

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view